Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 62175-302

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 62175-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Rabeprazole Sodium Delayed Release Tablets 1)

FDA Label Image

Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)

Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)
This appears to be a table displaying data from a study comparing the effectiveness of a placebo treatment to two different doses of a medication for heartburn. The treatments being studied are referred to as "PLACEBO," "RAB 10mg," and "RAB 20mg" and the number of participants in each treatment group is also listed. The table has columns for "DAY," with dates displayed, and "Heartburn Scores," which are measured on a scale from 0 (no heartburn) to 4 (very severe heartburn).*
FDA Label Image

Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)

Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)
This text appears to be the results of a study or clinical trial comparing the effects of a placebo and two different doses of a drug called RAB. The sample sizes for each group are listed, with 68 participants in the placebo group, 64 participants in the RAB 10mg group, and 67 participants in the RAB 20mg group.*
FDA Label Image

Figure 4 (Rabeprazole Sodium Delayed Release Tablets 4)

FDA Label Image

Figure 5 (Rabeprazole Sodium Delayed Release Tablets 5)

FDA Label Image

20 mg 30 Count Bottle Label (Rabeprazole Sodium Delayed Release Tablets 6)

20 mg 30 Count Bottle Label (Rabeprazole Sodium Delayed Release Tablets 6)
This is a medication called Rabeprazole Sodium sold as Loenzar Plus Tablet. The tablets have a concentration of 20 mg and are packaged in a container with NDC number 62175-302-32. It is advised to store the tablets at room temperature and protect them from moisture. Dispensing should be done in a tightly enclosed container for safekeeping. Detailed information on the dosage and use can be found in the accompanying prescription. The distributor of this medication is Print Medicafion Guides at Lomnet Company Inc. based in Philadelphia. The data provided was last revised in August 2020.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.